These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 21330599)

  • 1. cGMP signals modulate cAMP levels in a compartment-specific manner to regulate catecholamine-dependent signaling in cardiac myocytes.
    Stangherlin A; Gesellchen F; Zoccarato A; Terrin A; Fields LA; Berrera M; Surdo NC; Craig MA; Smith G; Hamilton G; Zaccolo M
    Circ Res; 2011 Apr; 108(8):929-39. PubMed ID: 21330599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between phosphodiesterases in the regulation of the cardiac β-adrenergic pathway.
    Zhao CY; Greenstein JL; Winslow RL
    J Mol Cell Cardiol; 2015 Nov; 88():29-38. PubMed ID: 26388264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compartmentalized phosphodiesterase-2 activity blunts beta-adrenergic cardiac inotropy via an NO/cGMP-dependent pathway.
    Mongillo M; Tocchetti CG; Terrin A; Lissandron V; Cheung YF; Dostmann WR; Pozzan T; Kass DA; Paolocci N; Houslay MD; Zaccolo M
    Circ Res; 2006 Feb; 98(2):226-34. PubMed ID: 16357307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. cGMP-cAMP interplay in cardiac myocytes: a local affair with far-reaching consequences for heart function.
    Stangherlin A; Zaccolo M
    Biochem Soc Trans; 2012 Feb; 40(1):11-4. PubMed ID: 22260658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of phosphodiesterases in the regulation of the cardiac cyclic nucleotide cross-talk signaling network.
    Zhao CY; Greenstein JL; Winslow RL
    J Mol Cell Cardiol; 2016 Feb; 91():215-27. PubMed ID: 26773602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Implications for PDE2 and cGMP/cAMP Mediated Crosstalk in Cardiovascular Diseases.
    Sadek MS; Cachorro E; El-Armouche A; Kämmerer S
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PDE2-mediated cAMP hydrolysis accelerates cardiac fibroblast to myofibroblast conversion and is antagonized by exogenous activation of cGMP signaling pathways.
    Vettel C; Lämmle S; Ewens S; Cervirgen C; Emons J; Ongherth A; Dewenter M; Lindner D; Westermann D; Nikolaev VO; Lutz S; Zimmermann WH; El-Armouche A
    Am J Physiol Heart Circ Physiol; 2014 Apr; 306(8):H1246-52. PubMed ID: 24531807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of type 5 phosphodiesterase counteracts β2-adrenergic signalling in beating cardiomyocytes.
    Isidori AM; Cornacchione M; Barbagallo F; Di Grazia A; Barrios F; Fassina L; Monaco L; Giannetta E; Gianfrilli D; Garofalo S; Zhang X; Chen X; Xiang YK; Lenzi A; Pellegrini M; Naro F
    Cardiovasc Res; 2015 Jun; 106(3):408-20. PubMed ID: 25852085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac Hypertrophy Is Inhibited by a Local Pool of cAMP Regulated by Phosphodiesterase 2.
    Zoccarato A; Surdo NC; Aronsen JM; Fields LA; Mancuso L; Dodoni G; Stangherlin A; Livie C; Jiang H; Sin YY; Gesellchen F; Terrin A; Baillie GS; Nicklin SA; Graham D; Szabo-Fresnais N; Krall J; Vandeput F; Movsesian M; Furlan L; Corsetti V; Hamilton G; Lefkimmiatis K; Sjaastad I; Zaccolo M
    Circ Res; 2015 Sep; 117(8):707-19. PubMed ID: 26243800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained exposure to catecholamines affects cAMP/PKA compartmentalised signalling in adult rat ventricular myocytes.
    Fields LA; Koschinski A; Zaccolo M
    Cell Signal; 2016 Jul; 28(7):725-32. PubMed ID: 26475678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic nucleotide phosphodiesterase-mediated integration of cGMP and cAMP signaling in cells of the cardiovascular system.
    Maurice DH
    Front Biosci; 2005 May; 10():1221-8. PubMed ID: 15769620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphodiesterase-2 is up-regulated in human failing hearts and blunts β-adrenergic responses in cardiomyocytes.
    Mehel H; Emons J; Vettel C; Wittköpper K; Seppelt D; Dewenter M; Lutz S; Sossalla S; Maier LS; Lechêne P; Leroy J; Lefebvre F; Varin A; Eschenhagen T; Nattel S; Dobrev D; Zimmermann WH; Nikolaev VO; Vandecasteele G; Fischmeister R; El-Armouche A
    J Am Coll Cardiol; 2013 Oct; 62(17):1596-606. PubMed ID: 23810893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between cGMP- and cAMP-pathways are involved in the regulation of penile smooth muscle tone.
    Uckert S; Hedlund P; Waldkirch E; Sohn M; Jonas U; Andersson KE; Stief CG
    World J Urol; 2004 Oct; 22(4):261-6. PubMed ID: 15045518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of C-type natriuretic peptide-induced cGMP and functional responses by PDE2 and PDE3 in failing myocardium.
    Moltzau LR; Meier S; Aronsen JM; Afzal F; Sjaastad I; Skomedal T; Osnes JB; Levy FO; Qvigstad E
    Naunyn Schmiedebergs Arch Pharmacol; 2014 May; 387(5):407-17. PubMed ID: 24424715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microdomain switch of cGMP-regulated phosphodiesterases leads to ANP-induced augmentation of β-adrenoceptor-stimulated contractility in early cardiac hypertrophy.
    Perera RK; Sprenger JU; Steinbrecher JH; Hübscher D; Lehnart SE; Abesser M; Schuh K; El-Armouche A; Nikolaev VO
    Circ Res; 2015 Apr; 116(8):1304-11. PubMed ID: 25688144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanodomain Regulation of Cardiac Cyclic Nucleotide Signaling by Phosphodiesterases.
    Kokkonen K; Kass DA
    Annu Rev Pharmacol Toxicol; 2017 Jan; 57():455-479. PubMed ID: 27732797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDE2 at the crossway between cAMP and cGMP signalling in the heart.
    Weber S; Zeller M; Guan K; Wunder F; Wagner M; El-Armouche A
    Cell Signal; 2017 Oct; 38():76-84. PubMed ID: 28668721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic GMP and cyclic AMP induced changes in control and hypertrophic cardiac myocyte function interact through cyclic GMP affected cyclic-AMP phosphodiesterases.
    Weiss HR; Gong GX; Straznicka M; Yan L; Tse J; Scholz PM
    Can J Physiol Pharmacol; 1999 Jun; 77(6):422-31. PubMed ID: 10537228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphodiesterases and Compartmentation of cAMP and cGMP Signaling in Regulation of Cardiac Contractility in Normal and Failing Hearts.
    Calamera G; Moltzau LR; Levy FO; Andressen KW
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of human platelet responses by cGMP inhibited and stimulated cAMP phosphodiesterases.
    Manns JM; Brenna KJ; Colman RW; Sheth SB
    Thromb Haemost; 2002 May; 87(5):873-9. PubMed ID: 12038792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.